Comparison of glucose profiles of Insulin Lispro Mix 50 TID and Basal/Bolus Therapy in continuous glucose monitoring system.

Comparison of glucose profiles of Insulin Lispro Mix 50 TID and Basal/Bolus Therapy in continuous glucose monitoring system. - Comparison of glucose profiles of Insulin Lispro Mix 50 TID and Basal/Bolus Therapy in continuous glucose monitoring system.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011737

Enrollment

Registered

2013-09-12

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type2 diabetes

Interventions

Basal/Bolus Therapy Insulin Lispro Mix 50 TID

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c7.0-11% type2 diabetes

Exclusion criteria

Exclusion criteria: type1 diabetes

Design outcomes

Primary

Measure	Time frame
HbA1c glucose profile	—

Countries

Japan

Contacts

Public ContactNaofumi Fukuda

Yamaguchi University Hospital internal medicine 3

nfm6666@yamaguchi-u.ac.jp0836222563

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026